Pemetrexed

proprotein convertase subtilisin/kexin type 9 ; Homo sapiens







5 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30838090 FGF2-FGFR1 pathway activation together with thymidylate synthase upregulation is induced in pemetrexed-resistant lung cancer cells. 2019 Feb 5 3
2 29393480 Sensitivity to chemotherapeutics of NSCLC cells with acquired resistance to EGFR-TKIs is mediated by T790M mutation or epithelial-mesenchymal transition. 2018 Apr 1
3 27006151 Combination of Gefitinib and Pemetrexed Prevents the Acquisition of TKI Resistance in NSCLC Cell Lines Carrying EGFR-Activating Mutation. 2016 Jul 3
4 25676404 [Nimotuzumab significantly enhances chemosensitivity of
PC9 human lung adenocarcinoma cells to paclitaxel in vitro]. 2015 Feb 1
5 24840891 Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer. 2014 Aug 2